Using the new biomarker analysis device wouldn’t it be interesting to see the data from a clinical Alzheimer’s trial comparing blarcamesine with Aricept, Aduhelm, Leqembi, or any of the others so wonderfully approved for clinical use.
by falconer66a...
Back in the day, we would have used the Old Navy expression of..."kicking ass and taking names".